DBV Technologies S.A.(DBVT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

DBVT DBV Technologies S.A.

交易中 09-18 12:19:52 EDT

12.22

-0.29

-2.32%

最高12.59	最低12.14	成交量7.51万
今开12.59	昨收12.51	日振幅3.60%
总市值7.68亿	流通市值4.72亿	总股本6,285万
成交额92.77万	换手率0.19%	流通股本3,860万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"DBVT","market":"US","secType":"STK","nameCN":"DBV Technologies S.A.","latestPrice":12.22,"timestamp":1789748364952,"preClose":12.51,"halted":0,"volume":75097,"delay":0,"changeRate":-0.023181454836131026,"floatShares":38602500,"shares":62845800,"eps":-3.5,"marketStatus":"交易中","change":-0.29,"latestTime":"09-18 12:19:52 EDT","open":12.59,"high":12.59,"low":12.14,"amount":927682.628125,"amplitude":0.035971,"askPrice":12.28,"askSize":203,"bidPrice":12.16,"bidSize":11,"shortable":3,"etf":0,"ttmEps":-3.5,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1789761600000},"marketStatusCode":2,"adr":1,"adrRate":5,"listingDate":1413950400000,"exchange":"NASDAQ","adjPreClose":12.51,"preHourTrading":{"tag":"盘前","latestPrice":12.59,"preClose":12.51,"latestTime":"09:29 EDT","volume":1921,"amount":24179.482925,"timestamp":1789738170042,"change":0.08,"changeRate":0.006395,"amplitude":0.026379},"postHourTrading":{"tag":"盘后","latestPrice":12.51,"preClose":12.51,"latestTime":"16:10 EDT","volume":1108,"amount":13861.08,"timestamp":1789675803977,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.248824,"impliedVol":0.3555,"impliedVolPercentile":0.3095},"requestUrl":"/m/hq/s/DBVT","defaultTab":"news","newsList":[{"id":"2518272635","title":"Dbv Technologies盘中异动 股价大涨8.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518272635","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518272635?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:30","pubTimestamp":1741613459,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时30分，Dbv Technologies股票出现波动，股价快速上涨8.25%。截至发稿，该股报4.52美元/股，成交量4.8497万股，换手率0.24%，振幅0.00%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.00%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213059abf2fb8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213059abf2fb8d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DBVT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517166262","title":"Dbv Technologies盘中异动 早盘股价大跌5.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517166262","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517166262?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:51","pubTimestamp":1741272707,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时51分，Dbv Technologies股票出现异动，股价快速跳水5.63%。Dbv Technologies股票所在的生物技术行业中，整体跌幅为0.67%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306225147963c5191&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306225147963c5191&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DBVT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517910072","title":"Dbv Technologies盘中异动 股价大跌5.35%报4.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517910072","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517910072?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:30","pubTimestamp":1741185043,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时30分，Dbv Technologies股票出现异动，股价大幅跳水5.35%。截至发稿，该股报4.07美元/股，成交量365股，换手率0.00%，振幅0.00%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.00%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223043989d4589&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223043989d4589&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DBVT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517098348","title":"Dbv Technologies盘中异动 下午盘大幅拉升8.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517098348","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517098348?lang=zh_cn&edition=full","pubTime":"2025-03-05 03:49","pubTimestamp":1741117758,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日03时49分，Dbv Technologies股票出现波动，股价大幅拉升8.33%。截至发稿，该股报4.29美元/股，成交量6073股，换手率0.03%，振幅5.05%。Dbv Technologies股票所在的生物技术行业中，整体跌幅为0.01%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305034919989bf4f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305034919989bf4f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DBVT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516341226","title":"Dbv Technologies盘中异动 股价大跌8.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516341226","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516341226?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:33","pubTimestamp":1741012404,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时33分，Dbv Technologies股票出现波动，股价急速跳水8.99%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.21%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223324abe633f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223324abe633f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DBVT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514202563","title":"Dbv Technologies盘中异动 早盘股价大跌6.43%报3.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514202563","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514202563?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:43","pubTimestamp":1740753830,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时43分，Dbv Technologies股票出现异动，股价急速下挫6.43%。截至发稿，该股报3.93美元/股，成交量4017股，换手率0.02%，振幅0.41%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.17%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022822435198967cf9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022822435198967cf9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DBVT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513722215","title":"Dbv Technologies盘中异动 早盘股价大跌5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513722215","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513722215?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:41","pubTimestamp":1740408083,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时41分，Dbv Technologies股票出现波动，股价大幅下挫5.35%。截至发稿，该股报4.16美元/股，成交量2295股，换手率0.01%，振幅0.91%。Dbv Technologies股票所在的生物技术行业中，整体跌幅为0.06%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224224124a25216cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224224124a25216cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DBVT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513215896","title":"Dbv Technologies盘中异动 股价大涨7.98%报4.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513215896","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513215896?lang=zh_cn&edition=full","pubTime":"2025-02-22 01:54","pubTimestamp":1740160498,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日01时54分，Dbv Technologies股票出现异动，股价大幅拉升7.98%。截至发稿，该股报4.60美元/股，成交量4995股，换手率0.02%，振幅9.15%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.44%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222015458abd7daaf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222015458abd7daaf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DBVT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511487525","title":"Dbv Technologies盘中异动 股价大涨6.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511487525","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511487525?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:32","pubTimestamp":1739457148,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日22时32分，Dbv Technologies股票出现波动，股价大幅拉升6.11%。截至发稿，该股报4.37美元/股，成交量625股，换手率0.00%，振幅0.00%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.17%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223228abcdb26b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223228abcdb26b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DBVT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510351579","title":"Dbv Technologies盘中异动 下午盘急速拉升6.65%报4.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510351579","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510351579?lang=zh_cn&edition=full","pubTime":"2025-02-12 03:54","pubTimestamp":1739303644,"startTime":"0","endTime":"0","summary":"北京时间2025年02月12日03时54分，Dbv Technologies股票出现异动，股价快速拉升6.65%。截至发稿，该股报4.47美元/股，成交量9791股，换手率0.05%，振幅9.87%。Dbv Technologies股票所在的生物技术行业中，整体跌幅为1.75%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212035404961f7be0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212035404961f7be0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DBVT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509200387","title":"Dbv Technologies盘中异动 大幅跳水6.44%报4.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509200387","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509200387?lang=zh_cn&edition=full","pubTime":"2025-02-07 02:26","pubTimestamp":1738866417,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日02时26分，Dbv Technologies股票出现波动，股价快速跳水6.44%。截至发稿，该股报4.29美元/股，成交量1.6438万股，换手率0.08%，振幅1.53%。Dbv Technologies股票所在的生物技术行业中，整体跌幅为0.19%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207022657a23bfed4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207022657a23bfed4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DBVT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508457616","title":"Dbv Technologies盘中异动 早盘快速拉升9.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508457616","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508457616?lang=zh_cn&edition=full","pubTime":"2025-02-04 22:30","pubTimestamp":1738679425,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日22时30分，Dbv Technologies股票出现波动，股价大幅拉升9.36%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.00%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204223025987a4a04&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204223025987a4a04&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DBVT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508142853","title":"Dbv Technologies盘中异动 大幅下跌9.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508142853","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508142853?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:38","pubTimestamp":1738593509,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时38分，Dbv Technologies股票出现波动，股价快速下跌9.82%。Dbv Technologies股票所在的生物技术行业中，整体跌幅为0.39%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502032238299616fce7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502032238299616fce7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DBVT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507961066","title":"Dbv Technologies盘中异动 大幅上涨6.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507961066","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507961066?lang=zh_cn&edition=full","pubTime":"2025-01-31 23:33","pubTimestamp":1738337587,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日23时33分，Dbv Technologies股票出现异动，股价大幅拉升6.57%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为1.38%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025013123330798776713&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025013123330798776713&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DBVT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507447632","title":"Dbv Technologies盘中异动 股价大跌5.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507447632","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507447632?lang=zh_cn&edition=full","pubTime":"2025-01-29 23:10","pubTimestamp":1738163432,"startTime":"0","endTime":"0","summary":"北京时间2025年01月29日23时10分，Dbv Technologies股票出现异动，股价大幅跳水5.80%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.53%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129231032abbc6290&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129231032abbc6290&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DBVT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506126795","title":"Dbv Technologies盘中异动 早盘大幅下挫5.56%报4.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506126795","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506126795?lang=zh_cn&edition=full","pubTime":"2025-01-28 22:59","pubTimestamp":1738076340,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日22时59分，Dbv Technologies股票出现波动，股价急速下挫5.56%。截至发稿，该股报4.27美元/股，成交量3562股，换手率0.02%，振幅2.32%。Dbv Technologies股票所在的生物技术行业中，整体跌幅为0.01%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128225900a23274d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128225900a23274d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DBVT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506946028","title":"Dbv Technologies盘中异动 股价大跌5.68%报4.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506946028","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506946028?lang=zh_cn&edition=full","pubTime":"2025-01-25 02:37","pubTimestamp":1737743867,"startTime":"0","endTime":"0","summary":"北京时间2025年01月25日02时37分，Dbv Technologies股票出现异动，股价快速下挫5.68%。截至发稿，该股报4.15美元/股，成交量1.7442万股，换手率0.09%，振幅8.86%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.23%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125023748abb78253&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125023748abb78253&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DBVT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505011262","title":"Dbv Technologies盘中异动 早盘快速跳水5.70%报4.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505011262","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505011262?lang=zh_cn&edition=full","pubTime":"2025-01-23 22:31","pubTimestamp":1737642686,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日22时31分，Dbv Technologies股票出现异动，股价急速下跌5.70%。截至发稿，该股报4.47美元/股，成交量2132股，换手率0.01%，振幅0.00%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.02%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123223126a22d0938&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123223126a22d0938&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DBVT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505270267","title":"Dbv Technologies盘中异动 早盘股价大涨5.04%报4.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505270267","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505270267?lang=zh_cn&edition=full","pubTime":"2025-01-21 23:29","pubTimestamp":1737473367,"startTime":"0","endTime":"0","summary":"北京时间2025年01月21日23时29分，Dbv Technologies股票出现波动，股价快速上涨5.04%。截至发稿，该股报4.69美元/股，成交量1.2216万股，换手率0.06%，振幅1.57%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为1.28%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121232927960bc506&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121232927960bc506&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DBVT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2504114897","title":"Dbv Technologies盘中异动 股价大跌5.60%报4.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2504114897","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2504114897?lang=zh_cn&edition=full","pubTime":"2025-01-18 05:00","pubTimestamp":1737147638,"startTime":"0","endTime":"0","summary":"北京时间2025年01月18日05时00分，Dbv Technologies股票出现异动，股价快速跳水5.60%。截至发稿，该股报4.47美元/股，成交量3.2552万股，换手率0.16%，振幅4.86%。Dbv Technologies股票所在的生物技术行业中，整体跌幅为0.64%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250118050038a2260fad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250118050038a2260fad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DBVT"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.dbvtechnologies.com;www.dbv-technologies.com","stockEarnings":[{"period":"1week","weight":-0.0355},{"period":"1month","weight":-0.1355},{"period":"3month","weight":-0.1945},{"period":"6month","weight":-0.3447},{"period":"1year","weight":0.2677},{"period":"ytd","weight":-0.3474}],"compareEarnings":[{"period":"1week","weight":0.0063},{"period":"1month","weight":-0.0063},{"period":"3month","weight":0.0212},{"period":"6month","weight":0.1758},{"period":"1year","weight":0.1569},{"period":"ytd","weight":0.1183}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"DBV Technologies S.A.该公司于2002年3月29日根据法兰西共和国法律注册成立。该公司是一家临床阶段的专业生物制药公司，专注于通过开发名为Viaskin的新型技术平台来改变免疫治疗领域。该公司的治疗方法基于表皮免疫疗法，即EPIT，这是其使用Viaskin通过完整皮肤向免疫系统递送生物活性化合物的专有方法。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":0.061177},{"month":2,"riseRate":0.5,"avgChangeRate":-0.001378},{"month":3,"riseRate":0.5,"avgChangeRate":0.046363},{"month":4,"riseRate":0.666667,"avgChangeRate":0.087499},{"month":5,"riseRate":0.25,"avgChangeRate":-0.028844},{"month":6,"riseRate":0.333333,"avgChangeRate":0.021215},{"month":7,"riseRate":0.416667,"avgChangeRate":0.040676},{"month":8,"riseRate":0.416667,"avgChangeRate":-0.026095},{"month":9,"riseRate":0.25,"avgChangeRate":-0.086024},{"month":10,"riseRate":0.181818,"avgChangeRate":-0.114027},{"month":11,"riseRate":0.5,"avgChangeRate":0.015604},{"month":12,"riseRate":0.666667,"avgChangeRate":0.01819}],"exchange":"NASDAQ","name":"DBV Technologies S.A.","nameEN":"DBV Technologies SA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.0","shortVersion":"4.50.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"DBV Technologies S.A.(DBVT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供DBV Technologies S.A.(DBVT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"DBV Technologies S.A.,DBVT,DBV Technologies S.A.股票,DBV Technologies S.A.股票老虎,DBV Technologies S.A.股票老虎国际,DBV Technologies S.A.行情,DBV Technologies S.A.股票行情,DBV Technologies S.A.股价,DBV Technologies S.A.股市,DBV Technologies S.A.股票价格,DBV Technologies S.A.股票交易,DBV Technologies S.A.股票购买,DBV Technologies S.A.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"DBV Technologies S.A.(DBVT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供DBV Technologies S.A.(DBVT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}